Renal Anemia Treatment Market Expanding at 7.5% CAGR, Poised for US$ 14.15 Billion by 2034 | Fact.MR Report
09 déc. 2024 07h00 HE
|
FACT.MR
Rockville, MD, Dec. 09, 2024 (GLOBE NEWSWIRE) -- Treatment for renal anemia, a chronic condition also known as anemia of chronic kidney disease, primarily focuses on enhancing red blood cell...
Chronic Kidney Disease Market: 10-Year Growth Projections and Regional Insights
25 nov. 2024 07h13 HE
|
Research and Markets
Dublin, Nov. 25, 2024 (GLOBE NEWSWIRE) -- The "Chronic Kidney Disease: 68-Market Analysis and Sales Forecast" report has been added to ResearchAndMarkets.com's offering.This report covers the 68...
Critical Gaps in FSGS Treatment Highlight Need for New Therapies, with Pipeline Assets from Travere, Vertex, and Dimerix Poised to Address Unmet Needs
01 nov. 2024 09h17 HE
|
Spherix Global Insights
EXTON, PA, Nov. 01, 2024 (GLOBE NEWSWIRE) -- Focal segmental glomerulosclerosis (FSGS), one of the most common glomerular diseases seen by nephrologists, ranks among the top three rare kidney...
Unicycive Therapeutics Delivers Multiple Poster Presentations Highlighting Development Progress on Oxylanthanum Carbonate (OLC) and UNI-494 at the American Society of Nephrology (ASN) Kidney Week 2024
28 oct. 2024 07h03 HE
|
Unicycive Therapeutics, Inc.
– Late-Breaker Poster Presentation Highlights Favorable Safety & Tolerability of OLC – – Two Publications Recently Issued Featuring OLC and UNI-494 – LOS ALTOS, Calif., Oct....
Purespring Therapeutics presents new preclinical data on novel gene therapy for IgA Nephropathy at ASN Kidney Week 2024
28 oct. 2024 07h00 HE
|
Purespring Therapeutics
Results from the study underpin the potential of Purespring’s lead AAV gene therapy programme, PS-002, as an important novel modality to treat IgAN Data support progression towards a Phase I/II...
Chronic Kidney Disease (CKD) Drugs Market is projected to reach USD 23.8 Billion, garnering a 4.2% CAGR from 2024 to 2034: Transparency Market Research, Inc.
24 sept. 2024 08h32 HE
|
Transparency Market Research
Wilmington, Delaware, United States, Transparency Market Research Inc. -, Sept. 24, 2024 (GLOBE NEWSWIRE) -- The global chronic kidney disease (CKD) drugs market (만성신장질환(CKD) 치료제 시장) was projected...
ZyVersa Therapeutics' CEO, Stephen C. Glover, Is an Invited Speaker at H.C. Wainwright 3rd Annual Kidney Conference to be Held Virtually on July 15, 2024
09 juil. 2024 07h57 HE
|
ZyVersa Therapeutics
ZyVersa welcomes one-on-one meetings at the HCW Kidney Conference on July 15, 2024.
Unicycive Therapeutics Achieves Study Objective in Oxylanthanum Carbonate (OLC) Pivotal Clinical Trial
25 juin 2024 07h30 HE
|
Unicycive Therapeutics, Inc.
– Successfully Established Favorable Tolerability and Safety of OLC – – New Drug Application (NDA) Submission Anticipated in Q3 2024 – – Webcast and Conference Call Today at 8:30 A.M. ET – LOS...
Alta Semper acquires Allmed Group to deliver advanced blood purification and dialysis solutions worldwide
13 juin 2024 02h00 HE
|
AllMed
Alta Semper acquires Allmed Group to deliver advanced blood purification and dialysis solutions worldwide London, UK, 13th of June 2024; Allmed Group ("Allmed" or "the Company"), a...
AVEROA Submits Marketing Authorisation Application to the European Medicines Agency Seeking Approval of AVA1014 for Treating Complications Associated with Chronic Kidney Disease
23 avr. 2024 06h00 HE
|
Averoa
Grenoble, France, 23rd April 2024 - Averoa, a biopharmaceutical company bringing innovative therapeutic solutions to people with renal diseases, announces the submission of a marketing authorisation...